ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

Cancer Control Survey Determines Manpower Needs for Quality Care

July 9, 1976

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992